KBC Group
ELAN icon

KBC Group’s Elanco Animal Health ELAN Stock Holding History

KBC Group’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2M Sell
89,554
-2,231
-2% -$53.9K ﹤0.01% 659
2026
Q2 		$2.26M Hold
91,785
– – ﹤0.01% 664
2026
Q1 		$2.2M Buy
91,785
+1,639
+2% +$40.1K 0.01% 642
2025
Q4 		$2.04M Hold
90,146
– – ﹤0.01% 601
2025
Q3 		$1.82M Hold
90,146
– – ﹤0.01% 608
2025
Q2 		$1.29M Sell
90,146
-8,528
-9% -$100K ﹤0.01% 640
2025
Q1 		$1.04M Sell
98,674
-224,828
-69% -$2.54M ﹤0.01% 664
2024
Q4 		$3.92M Buy
323,502
+234,840
+265% +$3.07M 0.01% 537
2024
Q3 		$1.3M Buy
88,662
+63
+0.1% +$878 ﹤0.01% 659
2024
Q2 		$1.28M Buy
88,599
+1,577
+2% +$25.2K ﹤0.01% 639
2024
Q1 		$1.42M Sell
87,022
-43,930
-34% -$687K ﹤0.01% 630
2023
Q4 		$1.95M Sell
130,952
-7,056
-5% -$79.9K 0.01% 610
2023
Q3 		$1.55M Buy
138,008
+9,571
+7% +$111K 0.01% 626
2023
Q2 		$1.29M Sell
128,437
-8,284
-6% -$76.9K 0.01% 665
2023
Q1 		$1.28M Sell
136,721
-22,681
-14% -$268K 0.01% 699
2022
Q4 		$1.95M Buy
159,402
+57,832
+57% +$721K 0.01% 605
2022
Q3 		$1.26M Buy
101,570
+790
+0.8% +$13.8K 0.01% 632
2022
Q2 		$1.98M Buy
100,780
+11,949
+13% +$283K 0.01% 546
2022
Q1 		$2.32M Sell
88,831
-18,477
-17% -$492K 0.01% 558
2021
Q4 		$3.04M Sell
107,308
-30,586
-22% -$951K 0.01% 537
2021
Q3 		$4.4M Buy
137,894
+4,374
+3% +$147K 0.02% 495
2021
Q2 		$4.63M Buy
133,520
+23,481
+21% +$774K 0.02% 483
2021
Q1 		$3.24M Buy
110,039
+4,323
+4% +$133K 0.01% 557
2020
Q4 		$3.24M Buy
105,716
+5,290
+5% +$161K 0.01% 545
2020
Q3 		$2.8M Sell
100,426
-21,608
-18% -$548K 0.02% 528
2020
Q2 		$2.62M Buy
122,034
+61,166
+100% +$1.35M 0.02% 508
2020
Q1 		$1.36M Buy
60,868
+1,320
+2% +$36.2K 0.01% 634
2019
Q4 		$1.75M Sell
59,548
-190,173
-76% -$5.17M 0.01% 717
2019
Q3 		$6.64M Sell
249,721
-16,124
-6% -$484K 0.05% 392
2019
Q2 		$8.99M Buy
265,845
+28,320
+12% +$919K 0.07% 324
2019
Q1 		$7.62M Buy
+237,525
New +$7.31M 0.06% 345

Other funds holding ELAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Black Creek Investment Management
Black Creek Investment Management Toronto, Ontario, Canada $1.8B AUM 5.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Bowen Hanes & Co
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.43B AUM 31.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

KBC Group's ELAN Position: Q3 2026 in Review

KBC Group reduced its Elanco Animal Health (ELAN) stake by 2.4% in Q3 2026, selling an estimated $53.9K and leaving 89,554 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #659.

KBC Group first reported a position in ELAN in Q1 2019 and has held it in 31 quarters since. The position peaked at $8.99M in Q2 2019. 302 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • KBC Group held 89,554 shares of Elanco Animal Health worth $2M as of Q3 2026.
  • KBC Group sold 2,231 Elanco Animal Health shares in Q3 2026, an estimated $53.9K.
  • Elanco Animal Health made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #659 holding.
  • KBC Group first reported a position in Elanco Animal Health in Q1 2019 and has held it in 31 quarters since.
  • KBC Group's Elanco Animal Health position peaked at $8.99M in Q2 2019.
  • 302 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.